Doxycycline Does Not Increase Intraocular Pressure
Doxycycline does not increase intraocular pressure (IOP); in fact, the FDA label specifically warns about benign intracranial hypertension (pseudotumor cerebri) as a potential adverse effect of tetracyclines, not elevated IOP. 1
Key Evidence from FDA Drug Label
The FDA labeling for doxycycline clearly states: "Bulging fontanels in infants and benign intracranial hypertension in adults have been reported in individuals receiving tetracyclines. These conditions disappeared when the drug was discontinued." 1 This refers to increased intracranial pressure (pressure around the brain), not intraocular pressure (pressure inside the eye)—these are completely different clinical entities.
Clinical Context and Mechanism
- Benign intracranial hypertension causes papilledema (optic disc swelling) but does not directly elevate IOP
- The FDA label contains no warnings or precautions regarding elevated IOP or glaucoma risk with doxycycline use 1
- Research evidence actually demonstrates doxycycline's beneficial effects in glaucoma surgery, where it is used to reduce postoperative scarring after trabeculectomy 2, 3
Supporting Research Evidence
Studies show doxycycline has anti-fibrotic and anti-inflammatory properties in ocular tissues:
- Oral doxycycline successfully managed post-trabeculectomy complications while maintaining well-controlled IOP 2
- Topical doxycycline after trabeculectomy showed similar efficacy to mitomycin-C in preventing scarring without adverse IOP effects 3
- Doxycycline reduces corneal fibrosis through focal adhesion pathway suppression 4
Critical Distinction
Do not confuse intracranial hypertension with intraocular hypertension. While doxycycline can rarely cause benign intracranial hypertension (presenting with headache, vision changes from papilledema), this does not translate to elevated IOP or glaucoma risk. If a patient on doxycycline develops visual symptoms, evaluate for papilledema from intracranial hypertension, not for acute angle-closure or IOP elevation.
Clinical Bottom Line
Doxycycline is safe from an IOP perspective and can be prescribed without concern for causing ocular hypertension or glaucoma. Monitor patients for symptoms of intracranial hypertension (headache, transient visual obscurations) rather than IOP elevation.